Agile Therapeutics logo

Agile Therapeutics AGRX

$ 0.6 10.11%

Quarterly report 2024-Q2
added 08-12-2024

report update icon

Country

usaUSA

IPO year

2014

Industry

Drug manufacturers

Stock Exchange

NASDAQ CAPITAL

CEO

Mr. Alfred Altomari

Employees in the company

15

Shares

2.16 M

Market Cap[1]

$ 58.2 M

EBITDA (LTM)

$ -37.2 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.